151 related articles for article (PubMed ID: 14699149)
1. The cavity structure for docking the K(+)-competitive inhibitors in the gastric proton pump.
Asano S; Yoshida A; Yashiro H; Kobayashi Y; Morisato A; Ogawa H; Takeguchi N; Morii M
J Biol Chem; 2004 Apr; 279(14):13968-75. PubMed ID: 14699149
[TBL] [Abstract][Full Text] [Related]
2. Mutational analysis of putative SCH 28080 binding sites of the gastric H+,K+-ATPase.
Asano S; Matsuda S; Tega Y; Shimizu K; Sakamoto S; Takeguchi N
J Biol Chem; 1997 Jul; 272(28):17668-74. PubMed ID: 9211917
[TBL] [Abstract][Full Text] [Related]
3. A hybrid between Na+,K+-ATPase and H+,K+-ATPase is sensitive to palytoxin, ouabain, and SCH 28080.
Farley RA; Schreiber S; Wang SG; Scheiner-Bobis G
J Biol Chem; 2001 Jan; 276(4):2608-15. PubMed ID: 11054424
[TBL] [Abstract][Full Text] [Related]
4. A chimeric gastric H+,K+-ATPase inhibitable with both ouabain and SCH 28080.
Asano S; Matsuda S; Hoshina S; Sakamoto S; Takeguchi N
J Biol Chem; 1999 Mar; 274(11):6848-54. PubMed ID: 10066737
[TBL] [Abstract][Full Text] [Related]
5. Sites of reaction of the gastric H,K-ATPase with extracytoplasmic thiol reagents.
Besancon M; Simon A; Sachs G; Shin JM
J Biol Chem; 1997 Sep; 272(36):22438-46. PubMed ID: 9278394
[TBL] [Abstract][Full Text] [Related]
6. Conformation-dependent inhibition of gastric H+,K+-ATPase by SCH 28080 demonstrated by mutagenesis of glutamic acid 820.
Swarts HG; Hermsen HP; Koenderink JB; Willems PH; de Pont JJ
Mol Pharmacol; 1999 Mar; 55(3):541-7. PubMed ID: 10051539
[TBL] [Abstract][Full Text] [Related]
7. Identification of the site of inhibition by omeprazole of a alpha-beta fusion protein of the H,K-ATPase using site-directed mutagenesis.
Lambrecht N; Corbett Z; Bayle D; Karlish SJ; Sachs G
J Biol Chem; 1998 May; 273(22):13719-28. PubMed ID: 9593713
[TBL] [Abstract][Full Text] [Related]
8. [Possible mechanisms for (H+ + K+)-ATPase inhibition by proton pump inhibitors, omeprazole, lansoprazole and SCH 28080].
Nagaya H; Satoh H
Nihon Rinsho; 1992 Jan; 50(1):26-32. PubMed ID: 1311786
[TBL] [Abstract][Full Text] [Related]
9. Amino acids Val115-Ile126 of rat gastric H(+)-K(+)-ATPase confer high affinity for Sch-28080 to Na(+)-K(+)-ATPase.
Lyu RM; Farley RA
Am J Physiol; 1997 May; 272(5 Pt 1):C1717-25. PubMed ID: 9176164
[TBL] [Abstract][Full Text] [Related]
10. The negative charge of glutamic acid-820 in the gastric H+,K+-ATPase alpha-subunit is essential for K+ activation of the enzyme activity.
Hermsen HP; Swarts HG; Koenderink JB; De Pont JJ
Biochem J; 1998 Apr; 331 ( Pt 2)(Pt 2):465-72. PubMed ID: 9531486
[TBL] [Abstract][Full Text] [Related]
11. Role of negatively charged residues in the fifth and sixth transmembrane domains of the catalytic subunit of gastric H+,K+-ATPase.
Swarts HG; Klaassen CH; de Boer M; Fransen JA; De Pont JJ
J Biol Chem; 1996 Nov; 271(47):29764-72. PubMed ID: 8939913
[TBL] [Abstract][Full Text] [Related]
12. Antiulcer agents. 5. Inhibition of gastric H+/K(+)-ATPase by substituted imidazo[1,2-a]pyridines and related analogues and its implication in modeling the high affinity potassium ion binding site of the gastric proton pump enzyme.
Kaminski JJ; Wallmark B; Briving C; Andersson BM
J Med Chem; 1991 Feb; 34(2):533-41. PubMed ID: 1847427
[TBL] [Abstract][Full Text] [Related]
13. Soraprazan: setting new standards in inhibition of gastric acid secretion.
Simon WA; Herrmann M; Klein T; Shin JM; Huber R; Senn-Bilfinger J; Postius S
J Pharmacol Exp Ther; 2007 Jun; 321(3):866-74. PubMed ID: 17369284
[TBL] [Abstract][Full Text] [Related]
14. Functional expression of gastric H+,K(+)-ATPase and site-directed mutagenesis of the putative cation binding site and catalytic center.
Asano S; Tega Y; Konishi K; Fujioka M; Takeguchi N
J Biol Chem; 1996 Feb; 271(5):2740-5. PubMed ID: 8576249
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of the K+-competitive inhibitor site of gastric H,K-ATPase.
Vagin O; Munson K; Lambrecht N; Karlish SJ; Sachs G
Biochemistry; 2001 Jun; 40(25):7480-90. PubMed ID: 11412101
[TBL] [Abstract][Full Text] [Related]
16. Comparison of covalent with reversible inhibitor binding sites of the gastric H,K-ATPase by site-directed mutagenesis.
Lambrecht N; Munson K; Vagin O; Sachs G
J Biol Chem; 2000 Feb; 275(6):4041-8. PubMed ID: 10660561
[TBL] [Abstract][Full Text] [Related]
17. Mimicking of K+ activation by double mutation of glutamate 795 and glutamate 820 of gastric H+,K+-ATPase.
Hermsen HP; Swarts HG; Wassink L; Koenderink JB; Willems PH; De Pont JJ
Biochemistry; 2001 May; 40(21):6527-33. PubMed ID: 11371216
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological aspects of acid secretion.
Hirschowitz BI; Keeling D; Lewin M; Okabe S; Parsons M; Sewing K; Wallmark B; Sachs G
Dig Dis Sci; 1995 Feb; 40(2 Suppl):3S-23S. PubMed ID: 7859583
[TBL] [Abstract][Full Text] [Related]
19. Effects of mutations in M4 of the gastric H+,K+-ATPase on inhibition kinetics of SCH28080.
Munson KB; Lambrecht N; Sachs G
Biochemistry; 2000 Mar; 39(11):2997-3004. PubMed ID: 10715120
[TBL] [Abstract][Full Text] [Related]
20. Inhibitor and ion binding sites on the gastric H,K-ATPase.
Munson K; Garcia R; Sachs G
Biochemistry; 2005 Apr; 44(14):5267-84. PubMed ID: 15807521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
